Adamed Pharma competitive analysis

Latest publications and patents of Adamed Pharma New

Explore the latest publications and patents granted to Adamed Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Adamed Pharma

Oct 23, 2024A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And CaffeineGranted And Under Opposition
Sep 6, 2017A Pharmaceutical Composition Containing An Ace Inhibitor And A Calcium Channel BlockerOpposition Rejected

Explore patent oppositions filed by Adamed Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Tablets Comprising Tamsulosin And SolifenacinSYNTHONAug 9, 2024
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJul 11, 2023

Explore Adamed Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 23, 2024A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And Caffeine1
Sep 6, 2017A Pharmaceutical Composition Containing An Ace Inhibitor And A Calcium Channel Blocker1

Latest PTAB cases involving Adamed Pharma

Discover the latest PTAB cases involving Adamed Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adamed Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ADAMED PHARMA22 - - Aggressive
HOFFMANN EITLE147 - - - Highly Aggressive
MEDITOP GYOGYSZERIPARI KFT1 - - - Highly Aggressive
NOVARTIS6406 - 21Defensive